Sign In
Buy VEEV
$178.66
-4.29 (-2.34%)
At Close: Jun 03, 2026
Veeva Systems Inc. (VEEV) Presents at Raymond James TMT & Consumer Conference Transcript
01:47pm, Monday, 08'th Dec 2025
Veeva Systems Inc. (VEEV) Presents at Raymond James TMT & Consumer Conference Transcript
Dnca Finance Has $9.50 Million Position in Veeva Systems Inc. $VEEV
04:43am, Sunday, 07'th Dec 2025
Dnca Finance cut its position in shares of Veeva Systems Inc. (NYSE: VEEV) by 22.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange C
Veeva to Present at Upcoming Investor Conference
04:05pm, Thursday, 04'th Dec 2025
PLEASANTON, Calif. , Dec. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference: Raymond James 2025 TMT and Consumer Conference, New Yo
Les agents de Veeva AI sont désormais disponibles pour accroître la productivité et la centralité client
02:39am, Thursday, 04'th Dec 2025
/PRNewswire/ -- Lors d'une étape majeure pour Veeva AI, l'IA spécifique à l'industrie des sciences de la vie, Veeva Systems (NYSE: VEEV) a annoncé aujourd'hui
Why Veeva Systems' Earnings Drop Aligns With Its Long-Term Structural Weakness
11:23am, Wednesday, 03'rd Dec 2025
Veeva Systems (NYSE: VEEV) is currently in Phase 18, the final stage of its 18-phase Adhishthana cycle on the weekly charts. The company recently reported earnings, and the stock has fallen sharply si
Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
10:46am, Wednesday, 03'rd Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity
07:03am, Wednesday, 03'rd Dec 2025
Veeva AI delivers industry-specific AI for the next chapter in life sciences PLEASANTON, Calif. , Dec. 3, 2025 /PRNewswire/ -- In a major milestone for Veeva AI, industry-specific AI for life sciences
Head to Head Review: KORU Medical Systems (NASDAQ:KRMD) and Veeva Systems (NYSE:VEEV)
02:20am, Wednesday, 03'rd Dec 2025
Veeva Systems (NYSE: VEEV - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two busines
2 Growth Stocks With More Room to Run to Buy Ahead of 2026
04:26am, Tuesday, 02'nd Dec 2025
Netflix remains the king of streaming and has some near- and long-term catalysts that could jolt the stock. Veeva Systems leads a niche of the cloud market and should continue to perform well as it la
Veeva Systems: Unjustified Sell-Off, Justified Opportunity
11:54pm, Sunday, 30'th Nov 2025
Veeva Systems is rated a buy, with strong revenue and EPS growth, raised FY2026 guidance, and a misunderstood sell-off creating a long-term opportunity. VEEV's migration to Vault CRM is progressing we
Nutanix, Burlington Stores, Oracle and other major names led last week's steepest large-cap stock declines, driven by weak results and analyst downgrades.
Veeva Systems Inc. $VEEV Shares Sold by CDAM UK Ltd
03:46am, Friday, 28'th Nov 2025
CDAM UK Ltd reduced its stake in shares of Veeva Systems Inc. (NYSE: VEEV) by 4.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Com
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 27'th Nov 2025
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AXQ Capital LP Has $291,000 Stock Position in Veeva Systems Inc. $VEEV
04:36am, Tuesday, 25'th Nov 2025
AXQ Capital LP reduced its stake in Veeva Systems Inc. (NYSE: VEEV) by 27.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
Veeva (VEEV) International Revenue Performance Explored
10:15am, Monday, 24'th Nov 2025
Examine the evolution of Veeva's (VEEV) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
